Skip to main content
. 2017 Jul 27;8(56):95116–95134. doi: 10.18632/oncotarget.19618

Figure 2. Abemaciclib causes decreased cellular viability in RCC cell lines.

Figure 2

RCC cell lines were exposed to increasing concentrations of SGI-1776, abemaciclib, or palbociclib and cell viability determined by MTT assay. (A) 786-0 cells. (B) Caki-1 cells.